Elizabeth O'Farrell
Fortune : 934 312 $ au 31/05/2026
Fortune : 934 312 $ au 31/05/2026
Elizabeth G.
O'Farrell is Chairman at Geron Corp.
since 2025.
Ms. O'Farrell is Chairman at PDL BioPharma, Inc. since 2020.
Ms. O'Farrell is Independent Director at LENSAR, Inc. since 2021.
Ms. O'Farrell is Independent Director at SpyGlass Pharma, Inc. since 2025.
Ms. O'Farrell is Independent Director at Genmab A since 2022.
Ms. O'Farrell is Director at Karius, Inc. since 2023.
Former roles include Chief Financial Officer & Executive Director at Eli Lilly Canada, Inc., Director at Washington Township Schools Foundation from 2003 to 2010, Independent Director at Inhibikase Therapeutics, Inc. from 2019 to 2022, Director at Keep Indianapolis Beautiful, Inc., Director at Y.M.C.A. Foundation of Greater Indianapolis from 2016 to 2017, Chief Procurement Officer at Eli Lilly & Co. from 2012 to 2017, Accountant at OfficeMax Contract, Inc., Auditor at Pricewaterhouse LLP, Auditor at Whipple & Co., Manager at Somerset Financial Services LLC, and Chief Financial Officer, SVP-Policy & Finance at Lilly USA LLC.
Education includes an MBA degree conferred in 1987 and an undergraduate degree conferred in 1986, both from Indiana University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENMAB A/S 0 % | 17/02/2026 | 1 885 ( 0 % ) | 501 544 $ | 31/05/2026 |
LENSAR INC 0,56 % | 03/06/2026 | 67 368 ( 0,56 % ) | 390 734 $ | 31/05/2026 |
GERON CORPORATION 0,01 % | 20/05/2026 | 33 627 ( 0,01 % ) | 42 034 $ | 31/05/2026 |
| 05/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PDL BIOPHARMA, INC. | Président | 01/01/2020 |
| GERON CORPORATION | Président | 12/03/2025 |
| LENSAR, INC. | Directeur/Membre du Conseil | 01/02/2021 |
| GENMAB A/S | Directeur/Membre du Conseil | 29/03/2022 |
| SPYGLASS PHARMA, INC. | Directeur/Membre du Conseil | 01/08/2025 |
Karius, Inc.
Karius, Inc. Medical/Nursing ServicesHealth Services Operates as clinical and medical research laboratory to improve the diagnosis & treatment of infectious diseases for hospitals and physicians | Directeur/Membre du Conseil | 10/08/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2022 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/12/2017 |
Y.M.C.A. Foundation of Greater Indianapolis
Y.M.C.A. Foundation of Greater Indianapolis Miscellaneous Commercial ServicesCommercial Services Provides wellness programs | Président | 01/01/2017 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 18 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
OfficeMax Contract, Inc.
OfficeMax Contract, Inc. Forest ProductsNon-Energy Minerals Makes paper, office and building products | Non-Energy Minerals |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
LENSAR, Inc.
LENSAR, Inc. Medical SpecialtiesHealth Technology Develops femtosecond laser technologies for refractive cataract surgery | Health Technology |
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Pricewaterhouse LLP
Pricewaterhouse LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Health Technology |
Whipple & Co.
Whipple & Co. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Somerset Financial Services LLC
Somerset Financial Services LLC Investment ManagersFinance Provides financial services | Finance |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Washington Township Schools Foundation | |
Lilly USA LLC
Lilly USA LLC Pharmaceuticals: MajorHealth Technology Lilly USA LLC engages in the provision of pharmaceutical services. The company was founded on July 15, 2008 and is headquartered in Indianapolis, IN. | Health Technology |
Y.M.C.A. Foundation of Greater Indianapolis
Y.M.C.A. Foundation of Greater Indianapolis Miscellaneous Commercial ServicesCommercial Services Provides wellness programs | Commercial Services |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Karius, Inc.
Karius, Inc. Medical/Nursing ServicesHealth Services Operates as clinical and medical research laboratory to improve the diagnosis & treatment of infectious diseases for hospitals and physicians | Health Services |
Keep Indianapolis Beautiful, Inc.
Keep Indianapolis Beautiful, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an environmental and community non-profit organization | Commercial Services |
SpyGlass Pharma Inc
SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national